Cognex Reports Third Quarter 2026 Results
Key Highlights
- ➤Q3 revenue $313 million, up 13% year over year, reached a quarterly record
- ➤Adjusted EPS $0.53, up 61% year over year
- ➤Full-year 2026 revenue guidance raised to $1,143-$1,163 million
- ➤RealSense acquisition announced; all-cash transaction expected to close in Q4 2026
- ➤Q4 revenue guidance set at $270-$290 million, up 11% year over year
Expert Statements
Matt Moschner, President and CEO of Cognex
“Our third-quarter results reflect strong execution across the business, with record revenue, broad-based growth across most of our major end markets, and continued progress against our strategic objectives.”
Matt Moschner, President and CEO of Cognex
“We believe we are strengthening our leadership in AI-powered machine vision through innovation, expanding our long-term growth opportunity through the announced acquisition of RealSense, and continuing to help position Cognex to benefit from what we see as powerful trends in automation, robotics, and artificial intelligence.”
Dennis Fehr, CFO of Cognex
“We believe Q3 was another strong proof point for our profitable growth strategy.”
Dennis Fehr, CFO of Cognex
“Record revenue, significant margin expansion, and Adjusted EBITDA flow-through above 100% demonstrate the progress we have made transforming our operating model.”
Dennis Fehr, CFO of Cognex
“Our strong balance sheet and disciplined capital allocation strategy enabled us to pursue the RealSense acquisition, while retaining flexibility to invest in both organic and inorganic growth opportunities with the potential to create further value for shareholders.”
NATICK, Mass., Nov. 4, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today reported financial results for the third quarter ended October 4, 2026.
* Achieved record quarterly revenue of $313 million, an increase of 13% year over year, driven by broad-based strength across most major end markets; excluding the Q3 2025 one-time benefit from the commercial partnership with a medical lab automation channel partner (the "Commercial Partnership" or "CP"), revenue grew 19% year over year. * Operating margin was 32.2%; delivered an Adjusted EBITDA margin of 35.5%, up 1,060 basis points year over year. Excluding the CP, Adjusted EBITDA margin expanded 1,340 basis points year over year, marking the ninth consecutive quarter of margin expansion. * Net income per diluted share was $0.50; generated Adjusted diluted earnings per share of $0.53, up 61% year over year, representing the ninth consecutive quarter of growth. Excluding the CP, Adjusted EPS (diluted) increased 89% year over year. * Increased full-year 2026 guidance; continue to anticipate strong double-digit revenue growth and year-over-year expansion in profitability. * Announced the entry into a definitive agreement to acquire RealSense, Inc.
Get started
Create a free account to read the full story.